1. Home
  2. CRBU vs TAYD Comparison

CRBU vs TAYD Comparison

Compare CRBU & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • TAYD
  • Stock Information
  • Founded
  • CRBU 2011
  • TAYD 1955
  • Country
  • CRBU United States
  • TAYD United States
  • Employees
  • CRBU N/A
  • TAYD N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • TAYD Industrial Machinery/Components
  • Sector
  • CRBU Health Care
  • TAYD Industrials
  • Exchange
  • CRBU Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • CRBU 165.8M
  • TAYD 154.2M
  • IPO Year
  • CRBU 2021
  • TAYD N/A
  • Fundamental
  • Price
  • CRBU $1.78
  • TAYD $47.25
  • Analyst Decision
  • CRBU Strong Buy
  • TAYD
  • Analyst Count
  • CRBU 3
  • TAYD 0
  • Target Price
  • CRBU $6.67
  • TAYD N/A
  • AVG Volume (30 Days)
  • CRBU 729.3K
  • TAYD 8.9K
  • Earning Date
  • CRBU 11-05-2025
  • TAYD 09-26-2025
  • Dividend Yield
  • CRBU N/A
  • TAYD N/A
  • EPS Growth
  • CRBU N/A
  • TAYD 11.24
  • EPS
  • CRBU N/A
  • TAYD 2.87
  • Revenue
  • CRBU $9,121,000.00
  • TAYD $46,292,725.00
  • Revenue This Year
  • CRBU $9.23
  • TAYD $10.81
  • Revenue Next Year
  • CRBU N/A
  • TAYD $8.37
  • P/E Ratio
  • CRBU N/A
  • TAYD $16.53
  • Revenue Growth
  • CRBU N/A
  • TAYD 3.83
  • 52 Week Low
  • CRBU $0.66
  • TAYD $29.50
  • 52 Week High
  • CRBU $3.00
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 46.16
  • TAYD 51.77
  • Support Level
  • CRBU $1.72
  • TAYD $44.00
  • Resistance Level
  • CRBU $1.94
  • TAYD $48.61
  • Average True Range (ATR)
  • CRBU 0.11
  • TAYD 1.66
  • MACD
  • CRBU -0.01
  • TAYD -0.24
  • Stochastic Oscillator
  • CRBU 26.53
  • TAYD 46.76

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: